Newsmeme!
Discover News you didn't know existed

• home
• news
• tagging
• how it works
• about
• data

Larynx

News

ViroPharma Submits Supplemental Biologics License Application For Cinryze(TM) To Treat Acute Attacks Of Hereditary ...

Published December 2, 2008, 3:12 am, Medical News Today

ViroPharma Incorporated (Nasdaq: VPHM) announced that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Cinryze(TM) C1 Inhibitor (human) as a treatment for acute attacks of hereditary angioedema (HAE).

Full Story

Tags

No tags found at this time. Be the first to tag this news item, learn more.

Imagery

Related Larynx Stories

From Various News Sources

ViroPharma Inc. submits sBLA for Cinryze to treat acute attacks of ... - News-Medical.Net
ViroPharma Inc. has announced that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Cinryze C1 Inhibitor (human) as a treatment for acute attacks of hereditary angioedema ...

ViroPharma Submits Supplemental Biologics License Application for ... - StreetInsider.com
EXTON, Pa., Dec. 1 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM ) today announced that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Cinryze(TM) C1 ...

Related Social Bookmarks

None found at this time.